Latest Headlines
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 3,...
-
Check out Infection Control Today®’s highlights for the week ending February 3, 2023. https://t.co/p7bVQ0h3IV #norovirus @Gojo #intranasalvaccines #covid19 - view on twitter
Mashup Score:7
yourlocalepidemiologist.substack.comWhat ending the emergency actually means - 1 min
Mashup Score:7
The communication about ending the COVID-19 public health emergency (PHE) has been atrocious. We’re confused. Everyone’s confused. Dr. Rivers and I have been asking...
-
What does the end of the public health emergency mean for vaccines, treatments, disease surveillance, and more? @dr_kkjetelina and I have a roundup of what to expect in May. https://t.co/vKT7QygKEp - view on twitter
Mashup Score:1
AxiosImmunocompromised worry they’re getting left behind again - 1 min
Mashup Score:1
The immunocompromised have largely been an afterthought throughout the pandemic, patient advocacy groups...
-
“Evusheld made the immunocompromised ‘more comfortable doing daily tasks’” https://t.co/aHwHm6v5tp - view on twitter
The winter’s “tripledemic” of respiratory viruses impacted nearly 40 percent of U.S. households, with someone there getting sick with the flu, COVID-19 or respiratory...
-
“The flu affected 27 percent of households over the past month or so, with 15 percent saying someone in their homes got sick with COVID-19” https://t.co/wvXr7PBbN3 - view on twitter
Mashup Score:2
YouTubeA Message from the AARC President - 2 mins
Mashup Score:2
AARC President Carl Hinkson, MSc, RRT, RRT-ACCS, RRT-NPS, FAARC, addresses membership as he begins his two-year term as...
-
AARC President Carl Hinkson, MSc, RRT, RRT-ACCS, RRT-NPS, FAARC, addresses membership as he begins his two-year term as president. https://t.co/llYelXYm85 - view on twitter
Mashup Score:1
KFFKFF COVID-19 Vaccine Monitor: January 2023 - 3 mins
Mashup Score:1
This survey finds that nearly four-in-ten adults say their households were recently sick with COVID-19, the Flu, or RSV, and news of the viruses...
-
NEW: Nearly 4 in 10 people say someone in their household got sick recently from #COVID19, the flu or RSV, though most people say they aren’t worried about these viruses. Our survey has the details as the Feds move to end the public health emergency: https://t.co/bW6qcDRn3M https://t.co/bW6qcDRn3M - view on twitter
While glaucoma specialists are likely familiar with MicroPulse Laser Therapy (Iridex) as a non-incisional, non-pharmaceutical glaucoma therapy, two physicians called it an “ace up...
-
Tomas Grippo, MD, and Marc Toeteberg-Harms, MD, give their thoughts on MicroPulse, a non-incisional, non-pharmaceutical glaucoma therapy, for the anterior segment surgeon in this #EyeWorldMagazine article https://t.co/bc5v7J7qlk or https://t.co/bc5v7J7qlk #glaucoma https://t.co/bc5v7J7qlk - view on twitter
Description: In this webinar, you will learn hiring techniques and how to retain staff through an effective onboarding process....
-
MARK YOUR CALENDARS for the #ASOA February 15th webinar titled, "Hiring and Retention in Today's Tight Labor Market." Speaker: Debbie Davis, COE. https://t.co/dWHC4AbJVq #ophthalmology #practicemanagement #hiringandretention https://t.co/dWHC4AbJVq - view on twitter
Deadline to submit: March 15, 2023 Techniques and Innovations in Gastrointestinal Endoscopy (TIGE) invites original research article submissions on AI in Endoscopy and Innovation...
-
RT @AGA_TIGE: TIGE is seeking research on #AI in #Endoscopy and #GI Endoscopy Operations. Submit today! https://t.co/OOYErjDf9H https://t.c… - view on twitter
UV light emitting diodes (UV-LEDs) are energy efficient and of special interest for the inactivation of microorganisms. In context of the current pandemic, novel...
UV-LEDs are energy efficient and of special interest for the inactivation of microorganisms. In context of the current #pandemic, novel UV technologies can offer a powerful alternative of effective infection prevention and control #IPC https://t.co/Qg2eTSnlzl https://t.co/Qg2eTSnlzl - view on twitter